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Numerous reports on the familial occurrence of sarcoidosis, on regionally different prevalences and on its 
associations with genetic polymorphisms point to the existence of predisposing genes. We have started to establish 
a collection of DNA from families with two or more sarcoidosis patients for the purpose of genetic linkage and 
association studies. In this report we present HLA class II genotypes of affected first-degree relatives from 17 
families, including eight instances of affected parent and offspring, six sib pairs, and three sib triplets. Genotyping 
for HLA-DQBl revealed an over-representation of DQBl*O603 and DQB1*0604 among alleles shared by affected 
first degree relatives. The same was found for HLA-DPB1*0201 (Glu69 positive). However, none of the sib triplets 
had any of these alleles in common. 
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Introduction 
Sarcoidosis is a systemic granulomatous disease of 
unknown aetiology. It often takes an asymptomatic course 
or reveals unspecific subjective features that do not lead to 
appropriate diagnostic procedures. Therefore complete 
surveys on familial occurrence are difficult to perform. 
Jiirgensen (1) evaluated the data of a nationwide thoracic 
X-ray screening program in Germany. He demonstrated 
that 3.7% of 2471 individuals with radiographical signs of 
sarcoidosis had an equally affected first- or second-degree 
relative. Large families with several sarcoidosis patients 
have been found by Wiman (2) in the north of Sweden, and 
Wurm et ul. (3) have also described multiply affected 
families in Germany. Furthermore, numerous reports on 
associations between polymorphic genetic markers and 
sarcoidosis, such as HLA types, point to the existence of 
predisposing genes (4-7). 
We have started to establish a DNA bank from families 
with two or more sarcoidosis patients, a prerequisite for 
genetic association and linkage studies. Investigations on 
HLA class II genes are presented as the first results from 
this growing project, 
From the HLA class II gene cluster the polymorphic 
HLA-DQBl and HLA-DPBl genes were chosen for the 
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genotyping of sarcoidosis families. The variable HLA- 
DQBI gene is characterized by a manageable number of 
alleles with an even distribution of frequencies. In addition, 
the HLA-DQBl gene is closely linked to the HLA-DR 
locus. Thus indirect information about the HLA-DR geno- 
type can be derived from the results of HLA-DQBl typing. 
There is no close linkage, however, between HLA-DQBl 
and HLA-DPBl. The latter has been found to show a 
highly significant association with chronic beryllium disease 
(CBD) (8). CBD occurs almost exclusively in carriers of 
an HLA-DPBl allele with glutamate in position 69 of the 
amino acid sequence of the gene product (Glu69 positive). 
This finding is of interest in the context of our study, as 
sarcoidosis is very similiar to CBD with respect to clinical 
presentation and immunopathological mechanisms. 
Subjects and Methods 
Thirty-seven first-degree-related sarcoidosis patients from 
17 families were studied. The sample included eight 
instances of affected parent and offspring, six sib pairs and 
three sib triplets. Some of the families were found by 
inquiries among members of the German support group 
Deutsche Sarkoidose-Vereinigung (9). Others were con- 
tacted via a call for families addressed to German pulmo- 
logists or came from the authors’ clientele. All patients and 
their physicians were interviewed by telephone or question- 
naire. In 24 patients the diagnosis of sarcoidosis was 
confirmed by biopsies from affected organs. The remaining 
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FIG. 1. HLA-DQBl and HLA-DPBl genotypes of first-degree-related sarcoidosis patients from 17 families 
patients showed characteristic radiological signs in combi- All probands contributed a blood sample from which 
nation with clinical symptoms allowing the diagnosis of genomic DNA was extracted according to standard 
sarcoidosis. procedure. HLA genotyping was performed with a 
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commercially available kit (Inno-Lipa HLA; Innogenetics, 
Zwijndrecht, Belgium) following the supplier’s protocol. 
Briefly, exon 2 of the HLA-DQBl or HLA-DPBl gene was 
amplified by PCR using biotin-labelled primers. The 
labelled PCR products were hybridized to a variety of 
sequence-specific oligonucleotides immobilized in ordered 
arrays on filter membrane strips. After stringent washing of 
the strips, sequence specifically fixed PCR products were 
visualized by calorimetric biotin detection. This principle 
(10) gives information about the sequence at a distinct 
position of the exon under investigation. By combining the 
data from all oligonucleotides on the strip the genotype of 
the proband can be defined. 
HLA-DQBl and HLA-DPB 1 reference allele frequencies 
were adopted from the literature. Reil et al. (11) typed 177 
healthy Caucasian blood donors from northern Germany 
for HLA-DQBl with the same method that was used to 
analyse the sarcoidosis families of this study. HLA-DPBl 
allele frequencies were published by Begovich et al. (12) 
who studied 39 CEPH (Centre d’Etude du Polymorphisme 
Humain) families. These Caucasian families are widely 
used as a reference panel for genetic variations. They are 
considered to be representative for the northwest European 
population. 
Results and Discussion 
HLA-DQBl and HLA-DPBl typing data are listed in Fig. 
1. To our knowledge this report comprises the most exten- 
sive collection of HLA genotypes from sarcoidosis families 
published so far. However, the number of patients remains 
small and the individuals are related to another. Therefore 
a direct comparison of the allele frequencies between the 
study group and published data is not permitted. For more 
sophisticated statistical procedures of genetic linkage detec- 
tion the panel of sarcoidosis families is not (yet) sufficiently 
large. 
Nevertheless, some details appear to be noteworthy. In 
the sample of sarcoidosis families there are 23 instances of 
HLA-DQBZ alleles shared by two first-degree relatives 
within a family. Among these 23 shared HLA-DQB 1 alleles 
we found a striking overrepresentation of DQB 1*0603 and 
DQB1*0604 (observed 6/23, expected l/23). It is known 
that, as a result of linkage disequilibrium, DQBl”O603 
and DQBl”0604 are associated with DRB1*1301 and 
DRBl* 1302, and that these further correspond to HLA- 
DR6. Odum et al. (4) found the frequency of this phenotype 
increased in a sample of 41 sarcoidosis patients. An 
association between sarcoidosis and HLA-DR3/DR17 
has been reported repeatedly (6,13,14). These alleles are in 
linkage disequilibrium with DQB1*0201. In our study 
DQB1*0201 is overrepresented (observed 8/23, expected 
4/23) among alleles shared by affected relatives. HLA-DRS 
(5, 15), suspected to be another predisposing genotype, was 
not conspicuous in our sample. 
The distribution of HLA-DPBl alleles among sarcoidosis 
patients has been the issue of discordant reports. Saltini 
et al. (16) found no increase of DPB 1*0201 (Glu69 positive) 
alleles in a series of 24 sarcoidosis patients. However, 
Lympany et ~11. (17) noted a significant overrepresentation 
of DPBl”0201 and other Glu69-positive HLA-DPBl alleles 
in a sample of 41 affected individuals. In our study 24 
instances of HLA-DPBl alleles shared by affected relatives 
were observed in 17 sarcoidosis families. Among these 
DPB 1*0201 was notably overrepresented (observed 6124, 
expected 3/24). Thus our result supports the conclusion 
drawn by Lympany et al. (17) that Glu69-positive HLA- 
DPBl alleles could contribute to the genesis of sarcoidosis. 
Taken together, our as yet preliminary data from sar- 
coidosis families confirm some, but not all, published 
associations between sarcoidosis and HLA class II alleles. 
However, it is noteworthy that none of those alleles that are 
overrepresented among alleles shared by two affected rela- 
tives is actually present in all three members of any of the 
sib triplets in our sample. This fact argues against a crucial 
contribution of HLA-DQBl and HLA-DPBl genes to the 
pathogenesis of sarcoidosis at least in these three families. 
This finding is analogous to the report of Mijller et al. (18). 
They studied ten members of large sarcoidosis families from 
northern Sweden and excluded close genetic linkage to 
HLA class I genes. The discordant findings of overrepre- 
sentation of distinct HLA class II genes in sarcoidosis 
patients and lack of linkage in sarcoidosis families might be 
caused by a more complex genetic background. Heterogen- 
eity of the disorder itself and polygenic triggering of its 
course might also be involved. 
To gain significant results additional informative sar- 
coidosis families need to be studied. Established procedures 
of genetic linkage statistics can then be applied. Other 
polymorphisms should be included; among these, genetic 
markers from the centromeric region of chromosome 16 are 
especially promising. The Blau syndrome gene has recently 
been localized in this part of the human genome (19). 
Blau syndrome is a systemic granulomatous disease 
characterized by arthritis, uveitis and skin rash. It is inher- 
ited as an autosomal dominant trait. In addition, a gene 
predisposing to Crohn’s disease has been mapped to the 
same region of chromosome 16 (20). It might turn out that 
a gene involved in a variety of granulomatous disorders is 
located there. 
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